Cited by

• Cell cycle-specific metabolism of arabinosyl nucleosides in K562 human leukemia cells.

  Gandhi V, Plunkett W. Gandhi V, et al. Cancer Chemother Pharmacol. 1992;31(1):11-7. doi: 10.1007/BF00695988. Cancer Chemother Pharmacol. 1992. PMID: 1458554
• Pharmacokinetics and Model-Based Dosing to Optimize Fludarabine Therapy in Pediatric Hematopoietic Cell Transplant Recipients.

  Ivaturi V, Dvorak CC, Chan D, Liu T, Cowan MJ, Wahlstrom J, Stricherz M, Jennissen C, Orchard PJ, Tolar J, Pai SY, Huang L, Aweeka F, Long-Boyle J. Ivaturi V, et al. Biol Blood Marrow Transplant. 2017 Oct;23(10):1701-1713. doi: 10.1016/j.bbmt.2017.06.021. Epub 2017 Jul 3. Biol Blood Marrow Transplant. 2017. PMID: 28684371 Free PMC article. Clinical Trial.
• Antileukemic and immunosuppressive activity of 2-chloro-2'-deoxyadenosine.

  Carson DA, Wasson DB, Beutler E. Carson DA, et al. Proc Natl Acad Sci U S A. 1984 Apr;81(7):2232-6. doi: 10.1073/pnas.81.7.2232. Proc Natl Acad Sci U S A. 1984. PMID: 6585795 Free PMC article.
• Deoxycytidine kinase-mediated toxicity of deoxyadenosine analogs toward malignant human lymphoblasts in vitro and toward murine L1210 leukemia in vivo.

  Carson DA, Wasson DB, Kaye J, Ullman B, Martin DW Jr, Robins RK, Montgomery JA. Carson DA, et al. Proc Natl Acad Sci U S A. 1980 Nov;77(11):6865-9. doi: 10.1073/pnas.77.11.6865. Proc Natl Acad Sci U S A. 1980. PMID: 6256765 Free PMC article.
• Determination of intracellular fludarabine triphosphate in human peripheral blood mononuclear cells by LC-MS/MS.

  Huang L, Lizak P, Aweeka F, Long-Boyle J. Huang L, et al. J Pharm Biomed Anal. 2013 Dec;86:198-203. doi: 10.1016/j.jpba.2013.08.007. Epub 2013 Aug 23. J Pharm Biomed Anal. 2013. PMID: 24013121 Free PMC article.